ImmuCell Corporation (ICCC) Q2 FY25 Earnings Call

Q2 FY25 results, source: company transcript and SEC filings
QuarterQ2 FY25
Call date2025-08-15
Length36 minutes
EPS$0.06
Revenue$6.4M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q4 FY25

All ICCC earnings ยท Back to ICCC overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.